RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.
Clinical trial NCT04460898 · COMPLETED
Trial details
- NCT number
- NCT04460898
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-04
- Primary completion
- 2019-06-24
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.